Switch to:
Bio-Reference Laboratories Inc (NAS:BRLI)
Cash Flow for Capital Expenditures
$-23.1 Mil (TTM As of Jan. 2014)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Bio-Reference Laboratories Inc's cash flow for capital expenditures for the three months ended in Jan. 2014 was $-2.8 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jan. 2014 was $-23.1 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Bio-Reference Laboratories Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Jan. 2014 was -5.764 (Apr. 2013 ) + -7.031 (Jul. 2013 ) + -7.484 (Oct. 2013 ) + -2.771 (Jan. 2014 ) = $-23.1 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Bio-Reference Laboratories Inc Annual Data

Oct04Oct05Oct06Oct07Oct08Oct09Oct10Oct11Oct12Oct13
Cash Flow_CPEX -3.5-2.9-2.9-7.8-8.0-8.9-16.5-14.1-15.7-25.1

Bio-Reference Laboratories Inc Quarterly Data

Oct11Jan12Apr12Jul12Oct12Jan13Apr13Jul13Oct13Jan14
Cash Flow_CPEX -1.9-7.6-2.1-1.7-4.4-4.8-5.8-7.0-7.5-2.8
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide